Skip to search formSkip to main contentSkip to account menu

secondary acute myeloid leukemia

Known as: acute nonlymphocytic leukemia, secondary, nonlymphoblastic leukemia, secondary acute, nonlymphocytic leukemia, secondary acute 
An acute myeloid leukemia secondary to a myelodysplastic syndrome or therapy-related. (WHO, 2001)
National Institutes of Health

Related topics

Related topics

12 relations
Bone MarrowBone marrow stem cellFOXO3 geneFOXO3 wt Allele

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Current perspectives of nanoparticles in medical and dental biomaterials.
Nanotechnology is gaining tremendous impetus due to its capability of modulating metals into their nanosize, which drastically… 
Review
2007
Review
2007
Matrix metalloproteinases as mediators of primary and secondary cataracts
The matrix metalloproteinases (MMPs) are a family of endopeptidases involved in numerous remodeling and fibrotic disorders… 
Highly Cited
2002
Highly Cited
2002
Fifteen‐year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high‐dose irradiation
Summary. Between 1972 and 1988, 869 adult patients received MOPP (mechlorethamine, vincristine, procarbazine and prednisone; 462… 
Review
2001
Review
2001
Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy
Therapy-related MDS and AML are complications of intensive chemotherapy regimens. Traditionally, patients exposed to… 
Review
1998
Review
1998
The erythroid leukemias: a comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease.
Pure erythroid malignancies, such as Di Guglielmo disease (DG), in which the predominant immature elements are proerythroblasts… 
Highly Cited
1997
Highly Cited
1997
Secondary acute myelogenous leukemia following safe exposure to etoposide.
PURPOSE To present two patients as illustrations of the risk of developing secondary acute myelogenous leukemia (sAML) when… 
1993
1993
Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia.
Translocations at chromosomal band 11q23 characterize most de novo acute lymphoblastic leukemias (ALL) of infants, acute myeloid… 
1991
1991
A phase II clinical trial of carboplatin infusion in high-risk acute nonlymphoblastic leukemia.
Carboplatin (CBDCA) is a second-generation platinum drug that has been shown to be useful when used as a continuous infusion in… 
Highly Cited
1989
Highly Cited
1989
A two-step timed sequential treatment for acute myelocytic leukemia.
Since 1980, adults with acute myelocytic leukemia (AML) have been treated on two clinical studies using intensive timed… 
Highly Cited
1984
Highly Cited
1984
Secondary malignancies after marrow transplantation.
Secondary malignancies after marrow transplantation have been observed in 20 patients: 19 patients underwent marrow… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)